Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137689) titled 'A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function' on Aug. 17.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Eli Lilly and Company
Condition:
Renal Insufficiency
Intervention:
Drug: LY3537982
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: August 2025
Target Sample Size: 32
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07...